Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-24 @ 9:21 PM
NCT ID:
NCT03272204
Eligibility Criteria:
Inclusion Criteria:
* Pre-menopausal women between the ages of 18-50
* English-speaking
* Women with either natural growth/distribution of pubic hair or complete removal of pubic hair through a reversible process.
* Women who do not feel they have urinary or vaginal health problems and are not seeking care for these issues
* Women must be willing and able to complete study documentation and study procedures.
Exclusion Criteria: Women will be excluded for any of the following:
* Hair has been removed through an irreversible process like laser or electrolysis
* Patient feels they have bothersome urinary or pelvic floor conditions for which they are seeking care (for example: vaginal prolapse, frequent urinary incontinence, chronic pelvic pain, bladder pain)
* Patient plans on having any type of surgery in the next 2 months (due to likely antibiotic use)
* Patient has a history of a transplant and is on immunosuppression
* Patient has cancer for which she is currently getting chemotherapy or radiation
* Currently taking or has taken antibiotics in the last 7 days for any reason
* Patient has symptoms of a urinary tract or vaginal infection or is found on exam or culture to have a urinary tract infection or vaginal infection
* Patient is pregnant or breastfeeding
* Patient has douched in the last 48 hours
* Patient has had intercourse in the last 48 hours
* Patient is currently menstruating
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT03272204
Study Brief:
Protocol Section:
NCT03272204